SPDR Series Trust - State Street SPDR S&P Biotech ETF
US ˙ ARCA ˙ US78464A8707

SecurityXBI / SPDR Series Trust - State Street SPDR S&P Biotech ETF
InstitutionNvwm, Llc
Latest Disclosed Ownership13,654 shares
Latest Disclosed Value $ 1,744,045
Nvwm, Llc reports 0.26% increase in ownership of XBI / SPDR Series Trust - State Street SPDR S&P Biotech ETF

On April 27, 2026 - Nvwm, Llc filed a 13F-HR form disclosing ownership of 13,654 shares of SPDR Series Trust - State Street SPDR S&P Biotech ETF (US:XBI) valued at $1,744,025 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 20, 2026 disclosing 13,619 shares of SPDR Series Trust - State Street SPDR S&P Biotech ETF. This represents a change in shares of 0.26% during the quarter. The current value of the position is $1,772,699 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F STATE STREET SPDR S&P BIOTECH ETF ETF 78464A870 13,654 35 0.26 1,744 5.06 0.2045
2026-01-20 2025-12-31 13F STATE STREET SPDR S&P BIOTECH ETF ETF 78464A870 13,619 -303 -2.18 1,661 19.08 0.3613
2025-10-16 2025-09-30 13F SPDR S&P BIOTECH ETF ETF 78464A870 13,922 235 1.72 1,395 22.82 0.3137
2025-08-06 2025-06-30 13F SPDR S&P BIOTECH ETF ETF 78464A870 13,687 514 3.90 1,135 6.27 0.2740
2025-05-07 2025-03-31 13F SPDR S&P BIOTECH ETF ETF 78464A870 13,173 1,344 11.36 1,068 0.28 0.2838
2025-01-27 2024-12-31 13F SPDR S&P BIOTECH ETF ETF 78464A870 11,829 -858 -6.76 1,065 -15.00 0.2687
2024-10-29 2024-09-30 13F SPDR S&P BIOTECH ETF ETF 78464A870 12,687 83 0.66 1,253 7.28 0.3190
2024-08-13 2024-06-30 13F SPDR S&P BIOTECH ETF ETF 78464A870 12,604 6,465 105.31 1,169 100.69 0.3111
2024-05-07 2024-03-31 13F SPDR S&P BIOTECH ETF ETF 78464A870 6,139 1,361 28.48 583 36.62 0.1599
2024-02-08 2023-12-31 13F SPDR S&P BIOTECH ETF ETF 78464A870 4,778 -320 -6.28 427 14.52 0.1279
2023-10-30 2023-09-30 13F SPDR S&P BIOTECH ETF ETF 78464A870 5,098 57 1.13 372 -11.22 0.1217
2023-08-08 2023-06-30 13F SPDR S&P BIOTECH ETF ETF 78464A870 5,041 102 2.07 419 11.44 0.1364
2023-05-11 2023-03-31 13F SPDR S&P BIOTECH ETF ETF 78464A870 4,939 -11,325 -69.63 376 -72.13 0.1261
2023-02-14 2022-12-31 13F SPDR S&P BIOTECH ETF ETF 78464A870 16,264 -2,225 -12.03 1,350 -7.98 0.4903
2022-11-15 2022-09-30 13F SPDR S&P BIOTECH ETF ETF 78464A870 18,489 13,331 258.45 1,466 281.77 0.5818
2022-08-04 2022-06-30 13F SPDR S&P BIOTECH ETF ETF 78464A870 5,158 -2,429 -32.02 384 -43.70 0.1492
2022-05-11 2022-03-31 13F SPDR S&P BIOTECH ETF ETF 78464A870 7,587 762 11.16 682 -10.73 0.2162
2022-02-08 2021-12-31 13F SPDR S&P BIOTECH ETF ETF 78464A870 6,825 -12 -0.18 764 -11.16 0.2382
2021-11-03 2021-09-30 13F SPDR S&P BIOTECH ETF ETF 78464A870 6,837 186 2.80 860 -4.55 0.3094
2021-08-04 2021-06-30 13F SPDR S&P BIOTECH ETF ETF 78464A870 6,651 548 8.98 901 8.82 0.3238
2021-05-11 2021-03-31 13F SPDR S&P BIOTECH ETF ETF 78464A870 6,103 -60 -0.97 828 -4.61 0.3289
2021-02-09 2020-12-31 13F SPDR S&P BIOTECH ETF ETF 78464A870 6,163 -22 -0.36 868 25.80 0.3613
2020-12-10 2020-09-30 13F SPDR S&P BIOTECH ETF ETF 78464A870 6,185 6,173 51,441.67 690 68,900.00 0.3240
2020-08-11 2020-06-30 13F SPDR S&P BIOTECH ETF ETF 78464A870 12 0 0.00 1 0.00 0.0005
2020-05-08 2020-03-31 13F SPDR S&P BIOTECH ETF ETF 78464A870 12 0 0.00 1 0.00 0.0007
2020-02-07 2019-12-31 13F SPDR S&P BIOTECH ETF ETF 78464A870 12 -175 -93.58 1 -92.86 0.0006
2019-11-08 2019-09-30 13F/A-1 SPDR S&P BIOTECH ETF ETF 78464A870 187 -28 -13.02 14 -26.32 0.0086
2019-10-29 2019-09-30 13F SPDR S&P BIOTECH ETF ETF 78464A870 187 -28 14 0.0086
2019-08-07 2019-06-30 13F SPDR S&P BIOTECH ETF ETF 78464A870 215 -150 -41.10 19 -42.42 0.0115
2019-05-10 2019-03-31 13F SPDR S&P BIOTECH ETF ETF 78464A870 365 -34 -8.52 33 13.79 0.0219
2019-01-29 2018-12-31 13F SPDR S&P BIOTECH ETF ETF 78464A870 399 -22,271 -98.24 29 -98.67 0.0217
2018-11-14 2018-09-30 13F SPDR S&P BIOTECH ETF ETF 78464A870 22,670 1,039 4.80 2,173 5.54 1.3740
2018-08-01 2018-06-30 13F SPDR S&P BIOTECH ETF ETF 78464A870 21,631 526 2.49 2,059 16.33 1.4308
2018-05-17 2018-03-31 13F SPDR S&P BIOTECH ETF ETF 78464A870 21,105 14,336 211.79 1,770 208.36 1.2901
2018-03-15 2017-12-31 13F SPDR S&P BIOTECH ETF ETF 78464A870 6,769 6,769 574 0.4380
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.